Profile data is unavailable for this security.
About the company
Lotus Eye Hospital and Institute Limited is an India-based company, which is engaged in the business of healthcare activities. The Company is engaged in the field of ophthalmology (eye) and its related operations. It resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The Company provides various treatments, suchas ReLEx SMILE, Touchfree Laser, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The Company operates in various locations, such as Sitra, Coimbatore; RS Puram, Coimbatore; Salem; Tirupur; Mettupalayam; Kochi; Mulanthuruthy; Saravanampatty, and Karur.
- Revenue in INR (TTM)503.15m
- Net income in INR6.74m
- Incorporated1997
- Employees336.00
- LocationLotus Eye Hospital and Institute Ltd770/12 Avinashi Road, Civil Aerodrome post,COIMBATORE 641014IndiaIND
- Phone+91 4 224229999
- Fax+91 4 222627193
- Websitehttps://www.lotuseye.org/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nephro Care India Ltd | 676.68m | 33.97m | 1.31bn | 334.00 | 35.95 | 2.37 | 17.44 | 1.94 | 2.21 | 2.21 | 44.31 | 33.62 | 1.01 | 11.26 | 25.36 | 2,025,991.00 | 5.07 | -- | 6.22 | -- | 72.88 | -- | 5.02 | -- | 2.24 | 17.17 | 0.00 | -- | 69.04 | -- | -17.51 | -- | -- | -- |
| Maitreya Medicare Ltd | 459.98m | 832.35k | 1.42bn | -- | 1,700.73 | 4.50 | 85.53 | 3.08 | 0.1228 | 0.1228 | 67.88 | 46.43 | 0.9563 | 14.00 | 3.26 | -- | 0.1732 | -- | 0.2321 | -- | 79.87 | -- | 0.1812 | -- | 1.92 | 1.50 | 0.1174 | -- | -2.31 | -- | -36.95 | -- | -- | -- |
| Lotus Eye Hospital and Institute Ltd | 503.15m | 6.74m | 2.57bn | 336.00 | 358.07 | 4.24 | 75.82 | 5.11 | 0.3454 | 0.3454 | 24.96 | 29.15 | 0.7107 | 6.86 | 33.51 | -- | 0.9519 | 3.90 | 1.07 | 4.31 | 48.24 | 52.20 | 1.34 | 5.68 | 0.9039 | 1.04 | 0.0751 | -- | 2.81 | 4.09 | -74.63 | -7.03 | 14.81 | -- |
